The Antitrust Week in Review
Here are some of the developments in antitrust news this past week that we found interesting and are following.
. Federal courts often find the extent to which U.S. antitrust laws have a global reach to be one of the thorniest issues to deal with. The U.S. Court of Appeals for the Second Circuit is wrestling with this issue as it reviews a $147.8 million jury verdict against two Chinese vitamin C makers.
.  Two top supermarket chains are having a special sale – 168 stores – in order to win FTC approval of their $9.2 billion merger.
. Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle FTC charges that Sun’s $4 billion proposed acquisition of Ranbaxy would be anticompetitive. Completion of the deal would create the world’s fifth-largest  (and India’s largest) drug maker.
Tagged in: Antitrust Litigation,